Back to top

Tale of the Tape

Zacks Equity Research

Why BioTime (BTX) Stock Might be a Great Pick
November 25, 2016

BTX

Trades from $3

One stock that might be an intriguing choice for investors right now is BioTime, Inc. (BTX - Free Report) . This is because this security in the Medical-Biomedical/Genetics space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical-Biomedical/Genetics space as it currently has a Zacks Industry Rank of 71 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, BioTime is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

BIOTIME INC Price and Consensus

 

BIOTIME INC Price and Consensus | BIOTIME INC Quote

In fact, over the past month, current quarter estimates have narrowed from a loss of 22 cents per share to a loss of 18 cents per share, while current year estimates have narrowed from a loss of 72 cents per share to a loss of 55 cents per share. This has helped BTX to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

So, if you are looking for a decent pick in a strong industry, consider BioTime. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

In-Depth Zacks Research for the Tickers Above

BIOTIME INC (BTX) - FREE report >>